Paige Prostate
AI aid for detecting prostate cancer in core needle biopsies.
An assistive second look at prostate biopsies. It flags suspicious areas — it does not make the diagnosis, and you remain responsible for the report.
- Cost
- Paid
- Your data
- Not established
- Licence
- proprietary
- Maturity
- production
- From
- Paige.AI, Inc.
What it is
Software intended to assist pathologists in detecting areas suspicious for cancer in prostate core needle biopsy whole-slide images. Notable as the first AI device FDA authorised for pathology, creating the QPN product code.
Caveats
Clearance is specific to the indication for use stated in the FDA record and to the United States. It implies nothing about availability or approval elsewhere. Verify the current indication and your own jurisdiction's status before clinical use.
Related
Catalogued 2026-08-02, last checked 2026-08-02. View the source record · Report an error